CAS 166095-21-2

2H-1-Benzopyran-6-carbonitrile,4-[(4-chlorophenyl)(1H-imidazol-2-ylmethyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-,(3R,4S)-

Description:

2H-1-Benzopyran-6-carbonitrile, 4-[(4-chlorophenyl)(1H-imidazol-2-ylmethyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-, (3R,4S)-, is a complex organic compound characterized by its multi-functional structure, which includes a benzopyran core, a carbonitrile group, and an imidazole moiety. The presence of the 4-chlorophenyl group suggests potential for significant biological activity, possibly enhancing its interaction with biological targets. The stereochemistry indicated by (3R,4S)- denotes specific spatial arrangements of atoms, which can influence the compound's reactivity and interactions. This compound may exhibit properties such as solubility in organic solvents, potential for hydrogen bonding due to the hydroxyl group, and reactivity associated with the carbonitrile functional group. Its structural complexity suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting various biological pathways. However, detailed studies would be necessary to fully elucidate its properties, including its stability, reactivity, and biological activity.

Formula: C₂₂H₂₁ClN₄O₂

Synonyms:

• 2H-1-Benzopyran-6-carbonitrile,4-[(4-chlorophenyl)(1H-imidazol-2-ylmethyl)amino]-3,4-dihydro-3-hydroxy-2,2-dimethyl-,(3R-trans)-
• Bms 191095

BMS-191095

CAS: 166095-21-2

BMS-191095 is mitochondrial ATP-sensitive potassium (mitoKATP) channel activator.

Formula: C₂₂H₂₁ClN₄O₂

Purity: >99.99%

Color and Shape: Solid

Molecular weight: 408.88

Ref: TM-T10566

BMS-191095

CAS: 166095-21-2

BMS-191095

Purity: ≥98%

Molecular weight: 408.88g/mol

Ref: 54-BUP07008

BMS-191095

CAS: 166095-21-2

BMS-191095 is a novel drug that has been shown to have both anti-inflammatory and cardioprotective effects. It is an ATP channel opener that helps to restore mitochondrial membrane potential and prevents the induction of reactive oxygen species (ROS). BMS-191095 is also able to inhibit the production of nitric oxide (NO) from the enzyme Nω-nitro-l-arginine methyl ester (L-NAME), which causes vasodilation and the release of potassium ions from cardiac cells. This drug has been shown to be effective in animal models for heart disease, as well as in isolated heart muscle cells.

Formula: C₂₂H₂₁ClN₄O₂

Purity: Min. 95%

Molecular weight: 408.88 g/mol

Ref: 3D-RGA09521